Publication:
Pentoxifylline treatment of oligoasthenospermic men

Simple item page
dc.contributor.authorMicic, S. (7006493137)
dc.contributor.authorHadzi-Djokic, J. (6603561960)
dc.contributor.authorDotlic, R. (6603869546)
dc.contributor.authorTulic, C. (6602213245)
dc.date.accessioned2025-06-12T11:57:12Z
dc.date.available2025-06-12T11:57:12Z
dc.date.issued1988
dc.description.abstractA randomised group of 90 men with idiopathic oligoasthenozoospermia was subjected to control study with pentoxifylline. Pentoxifylline was given to 51 men 1200 mg daily for 3 months. The other group of 39 infertile men was followed during the same period of time. Significant improvement was observed, in treated group, in percentage of motile sperms and normal shaped sperms after 3 months treatment. This study emphasizes that pentoxifylline is a relatively good drug for restoring sperm motility and morphology in oligoasthenozoospermic men.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0024165957&partnerID=40&md5=8f867bdad10dda061544aed43757ee19
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/2003
dc.titlePentoxifylline treatment of oligoasthenospermic men
dspace.entity.typePublication

Files

Collections

Publikacije / Publications